chrisvoncsefalvay/vaers-outcomes huggingface dataset:
injured arm internally; osteoarthritis; This spontaneous case was reported by a consumer and describes the occurrence of LIMB INJURY (injured arm internally) and OSTEOARTHRITIS (osteoarthritis) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002A21A and 007M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced LIMB INJURY (injured arm internally). In 2021, the patient experienced OSTEOARTHRITIS (osteoarthritis). The patient was treated with CORTISONE from August 2021 to August 2021 for Adverse event, at an unspecified dose and frequency. At the time of the report, LIMB INJURY (injured arm internally) and OSTEOARTHRITIS (osteoarthritis) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, X-ray: osteoarthritis (abnormal) osteoarthritis.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient was not taking any concomitant medications.   Patient reported that the cortisone shot did not help   This case was linked to MOD-2021-293273 (Patient Link).
Marked pain of left arm at site of injection with inability to lift arm associated with localized swelling and erythema around shot site.
20 hours after shot i became very dizzy and confused i made it to my bed were i slept interrupted with night terrors' upset stomach and shaky legs this continued for two days 5 days later i became strong enough to continue with daily activities
The adverse events happened after taking the second of four oral typhoid vaccine pills. The second dose was taken at 1pm on 9/8/2012. At 0700 on 9/10/12 I broke out in hives over most of my body. Later that day I also had a fever of 102.6, headache, and body aches. I was advised to not take the third and fourt doses. Benadryl helped with the hives but again on 9/11/2012 I awoke to severe hives. Also, on 9/4/2012 I had injections of both the Hep A and polio booster and have no clue who the manufacturer is.
On day 7 after my second dose of the covid vaccine I woke up covered with hives. From that day on I have had full body hives and angioedema everyday.  I have been to multiple doctors ( general practice, allergists, dermatologist and rheumatologist) I have had 2 ER visits because my lips and face swell at times. No one has any idea on how to treat my condition.  I have been on multiple antihistamines as well as 2 rounds of oral steroids and 2 steroid injections. nothing helps.  I have had multiple blood draws and everything comes back normal other than CRP and ESR are both elevated. I have also had a skin biopsy that showed hives with no vasculitis.
I discovered a rash on her abdomin which was followed by a high fever of 103.7. I am waiting for the doctors office to open so I can schedule an appt or talk to a nurse.
Red rash and itching on left arm went away after two days then 2 days later came back bigger and redder than before and lasted about 4 days.  Has cleared up since. 1st day was very painful also.
Inbound call from customer to provide updated temperature excursion information. She also provided names and administration dates of improperly stored administered ROTATEQ that was not supported. See original AE case 02429442 which did not include un; This spontaneous report was received from Other and refers to a patient of unknown age and gender.  The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported.  On 06-JUL-2023, the patient started therapy with rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid, 2 ml, lot #1968385, expiration date: 22-MAY-2024, administered for prophylaxis (strength, and route of administration were not provided).  On 06-JUL-2023, inbound call from customer to provide updated temperature excursion information. She also provided names and administration dates of improperly stored administered ROTATEQ that was not supported. Temperature excusion occured on 20-JUN-2023 - 34.9F for 6 hours 34 minutes 0 seconds; 03-JUL-2023 - 51.4 F for 7 hours 33 minutes 0 seconds; 04-JUL-2023 - 51.1F for 24 hours 0 minutes 0 seconds; 05-JUL-2023 - 50.7F for 9 hours 27 minutes 0 seconds. See original AE case 02429442 which did not include unique patient identifiers. Company awareness date reflects the date the RA was originally made aware. Additional AE cases were created for all patients involved: 02430210 02430211 02430254 02430255 02430256 02430257 02430258 02430259 02430261 02430267 02430578 02430599 02430623 02430642 02430682 02430683 02430684 02430686 02430687 02430690 02430691 02430699 02430701.  No PQC. No additional information.
Erythema and ecchymosis distal to the deltoid muscle along the anterior upper arm
arm pain; This case was reported by a pharmacist via call center representative and described the occurrence of pain in arm in a 60-year-old female patient who received Herpes zoster (Shingrix) (batch number BB24A, expiry date 26th September 2021) for prophylaxis.   On 3rd July 2019, the patient received Shingrix (intramuscular) .5 ml. On 3rd July 2019, less than a day after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was not recovered/not resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix in left arm on 3rd July 2019, and experienced arm pain till the date of reporting it was not resolved. The patient was seeking information on this adverse event and treatment recommendations. The patient was referred to physician for medical care inquiry.
About 1 hour later, her left side of her face, her lips and tongue were numb. She says "it did get better but it is still numb"; About 1 hour later, her left side of her face, her lips and tongue were numb. She says "it did get better but it is still numb"; About 1 hour later, her left side of her face, her lips and tongue were numb". She says "it did get better but it is still numb"; left leg is really hurting; This is a spontaneous report from a contactable consumer (patient). This female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration at single dose on 03Jan2021 for Covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient stated that after receiving vaccine, "about 1 hour later, her left side of her face, her lips and tongue were numb". She says "it did get better but it is still numb".  She added that her "left leg is really hurting". It hurts when she touches it. The outcome of her left side of her face, her lips and tongue were numb was recovering and outcome of left leg is really hurting was unknown. The patient would like to know if she should receive the 2nd dose?   Information on the lot/batch number has been requested.
A report has been received from a Physician concerning a 2 year old, female subject, who had been receiving FLUMIST QUADRIVALENT (intranasal). FLUMIST QUADRIVALENT (intranasal) started on an unknown date. The reporter stated that the patient experienced expired FLUMIST QUADRIVALENT administered which started on 10-Mar-2015. The outcome of the event expired FLUMIST QUADRIVALENT administered is unknown. The report was considered to be non-serious.
Patient discharged after (3) day inpatient admission. Patient is a 92 y.o. female who presented to Hospital on 11/29/2021 with 3 days of cough, shortness of breath and weakness and found to be COVID-19 positive with hypoxia. CXR without evidence of opacities however given hypoxia in the setting of COVID-19 this is consistent with viral pneumonia. The patient's initial onset of symptoms: 11/26/202. She received 2 doses of the pfizer vaccine months prior, has not had the booster yet. While hospitalized she received remdesivir (4/5 days) and decadron 4/10 days. She has been weaned to room air. She was evaluated by PT/OT who recommended home with home assistance. Recommend post-hospital follow-up with PCP in 1-week.
Pt developed fever and excessive screaming and crying for a few hours, post vax, on 1/6/97. The annual follow-up states "autism."
CONFIRMED COVID-19 INFECTION; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 11-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On APR-2021, Laboratory data included: COVID-19 virus test (NR: not provided) Positive. On 15-APR-2021, the subject experienced confirmed covid-19 infection. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from confirmed covid-19 infection. This report was non-serious.
Note: I was breastfeeding at the time - postpartum. After I had been in the sun a good portion of the day. While I was sleeping, I started to itch; and in the morning I realized, chin and down my neck - was covered in hives that were very itchy. It was very itchy. I went to urgent care. They didn't identify the cause. They gave me a topical steroid cream. I took Benadryl after that for a few nights to sleep. The topical cream helped me with the itching. Over a course of a few days, the hives disappeared. In July, I had another episode - they weren't as bad; I had used more sunscreen. It was when I was in the sun. I was topical steroid cream again and this time it wasn't as bad.
While giving patient the vaccination the vaccine came out the side of the syringe between the needle and the syringe. Most of the vaccine ended up running down her arm. After consultation it was decided that she receive another full dose today as she did not receive half of the dose that was in the syringe.
circumoral numbness 3-4 days p/2nd shot on 9NOV or 10NOV; 20NOV for 3rd but still had numbness of tongue & abdo discomfort, nausea, h/a;
Had shingles vaccine 6 days ago and now notices red itchy rash at site of injection on right arm lateral side.
Intense tingling on palms and bottom; chills; weakness; stomach pain; chest pain; low grade fever; needed bed rest; This is a spontaneous report from a contactable consumer (Patient). A 58-years-old male patient received first dose of BNT162B2 (BNT162B2), Via an unspecified route of administration, administered in Arm Right on 09Jan2021 08:30 (Batch/Lot Number: EK9231) as single, dose 2 via an unspecified route of administration, administered in Arm Right on 30Jan2021 (Batch/Lot Number: EL9262) as single for covid-19 immunisation. The patient Medical history included glaucoma, asthma, hypersensitivity from an unknown date and unknown if ongoing. The patient's concomitant medications included simvastatin (SIMVASTATIN); atropine (ATROPINE); dorzolamide (DORZOLAMIDE); escitalopram oxalate (LATA) taken for an unspecified indication, start and stop date were not reported. The patient experienced intense tingling on palms and bottom (paraesthesia), chills (chills), weakness (asthenia), stomach pain (abdominal pain upper), chest pain (chest pain), low grade fever (pyrexia), needed bed rest (bed rest) on 09Feb2021. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 11Feb2021. Therapeutic measures were taken as a result of intense tingling on palms and bottom (paraesthesia), chills (chills), weakness (asthenia), stomach pain (abdominal pain upper), chest pain (chest pain), low grade fever (pyrexia), needed bed rest (bed rest). The outcome of events was recovering.
felt faint and had nausea, patient was sweating and heart rate increased, pupils dilated, head and eyes rolled back. Placed cold compress on back on neck, laid patient on the ground, raised the feet on the chair, monitored blood pressure, pulse, and breathing. EMS was called because it took longer than ten minutes for patient to start looking better. EMS confirmed the blood pressure, pulse, breathing, and oxygen levels were ok. They suggested to mom that patient goes to the hospital to get checked out.
cut where the needle went in; Got very ill; large red mark on my arm; large warm mark on arm; This case was reported by a consumer via interactive digital media and described the occurrence of injection site laceration in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced injection site laceration, unwell, erythema of extremities and skin warm. On an unknown date, the outcome of the injection site laceration, erythema of extremities and skin warm were not recovered/not resolved and the outcome of the unwell was unknown.   It was unknown if the reporter considered the injection site laceration, unwell, erythema of extremities and skin warm to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 29-JAN-2023 Reporter's Comment: This case was reported by a patient via interactive digital media. The patient received shingles vaccine and got very ill. The patient still had a large warm red mark on patients arm and cut where the needle went in. The follow-up could not be possible as no contact details were available.
Chills (couldn't get warm even with blankets and sweaters), Body/Muscle Aches, fever, and flu like symptoms.  Also soar lump under left arm, in armpit area (same arm vaccine was given)
12/28/01 diff. swallowing and diff. breathing and fatigue and cont. diff breathing. F/U went to Dr. did CXR and using albuterol inhaler. Stated has never had diphtheria shot before and never recall to tetnus?
About 2 weeks after 1st dose I experienced Heavy stomach aches, spasms, and vomiting. Tried to call the very next day after a bad night. At Urgent care they gave me a metabolic panel, COVID test, CBC, PLT, DISS, they returned that it was dehydration. Gave saline IV and was discharged. Was prescribed nausea medication but I felt worse after taking it. It was a day or two before I came about and felt better.
I had general reactions muscle aches and chills and fever; Within 36 hours these symptoms resolved. Christmas Eve -  legs were swelling.  Saw primary care dr. Still have swelling in legs. Prescribed Lasix 20 mg/day. It's not really helping.
swelling under my arm pits and it's pretty significant. It's the size of a baseball; booster; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 35 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 01), for COVID-19 Immunization, reaction(s): "she did not experience with 1st and 2nd dose of the Pfizer COVID vaccine"; Bnt162b2 (Dose: 02), for COVID-19 Immunization, reaction(s): "she did not experience with 1st and 2nd dose of the Pfizer COVID vaccine". The following information was reported: SWELLING (non-serious), outcome "unknown", described as "swelling under my arm pits and it's pretty significant. It's the size of a baseball"; IMMUNISATION (non-serious), outcome "unknown", described as "booster".  Additional Information: Reporter stated that she received a Comirnaty dose and said "I have a swelling under my arm pits, and it was pretty significant. It was the size of a baseball" she wanted to know if she is "in danger or some sort" as she did not have a reaction with her first 2 doses of Comirnaty. This is her booster dose, and she did not experience with 1st and 2nd dose of the Pfizer COVID vaccine. PQC was not present. Reporter seriousness for Swelling under armpits that are the size of a baseball was unspecified.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Numbness and tingling if fingers/toes, which progressed to numbness to just above knees and elbows in all 4 extremities.  One week after numbness, onset of generalized fatigue and myalgia most prominent in the RUE.  Diagnosed with acute inflammatory demyelinating polyradiculoneuropathy (AIDP) 11/9/16.
Feeling a little bad after the first primary dose; This spontaneous case was reported by a patient and describes the occurrence of FEELING ABNORMAL (Feeling a little bad after the first primary dose) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 00J20A) for COVID-19 vaccination.     Concurrent medical conditions included Seasonal allergy and Drug allergy (allergic to Sulfa).    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Jan-2021, the patient experienced FEELING ABNORMAL (Feeling a little bad after the first primary dose). On 15-Jan-2021, FEELING ABNORMAL (Feeling a little bad after the first primary dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.   This case was linked to MOD-2022-667374 (Patient Link).
had some mild Covid symptoms and testes positive for Covid; had some mild Covid symptoms and testes positive for Covid; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 58 year-old female patient received bnt162b2 (BNT162B2), administration date 01Dec2021 (Lot number: FF8839) at the age of 58 years as dose 3 (booster), single for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: VITAMIN D [COLECALCIFEROL]; FISH OIL; COQ 10; TURMERIC [CURCUMA LONGA]. Vaccination history included: Covid-19 vaccine (First dose, Lot No: EL3247), administration date: 25Feb2021, when the patient was 58 years old, for COVID-19 Immunization; Covid-19 vaccine (Second dose), administration date: 2021, when the patient was 58 years old, for COVID-19 Immunization. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "had some mild Covid symptoms and testes positive for Covid". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: positive.  Follow-up attempts are completed. No further information is expected.
swelled up; really hard; Tender; Itching; Really chilly; Red spot at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Red spot at injection site), VACCINATION SITE SWELLING (swelled up), VACCINATION SITE REACTION (really hard), VACCINATION SITE PAIN (Tender) and VACCINATION SITE PRURITUS (Itching) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20-2A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergy.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (Red spot at injection site). On 28-Jan-2021, the patient experienced VACCINATION SITE SWELLING (swelled up), VACCINATION SITE REACTION (really hard), VACCINATION SITE PAIN (Tender), VACCINATION SITE PRURITUS (Itching) and CHILLS (Really chilly). At the time of the report, VACCINATION SITE ERYTHEMA (Red spot at injection site), VACCINATION SITE SWELLING (swelled up), VACCINATION SITE REACTION (really hard), VACCINATION SITE PAIN (Tender), VACCINATION SITE PRURITUS (Itching) and CHILLS (Really chilly) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment or concomitant medications were reported.
Tachycardia (HR in the 110s), shortness of breath, chest pain 15 min post vax Observation and fluids Sxs resolved after 15 mins of close monitoring NKA
Blurring vision, light headedness, new onset RBBB (Right bundle branch block).
Missed second vaccination dose.; Tested positive for COVID-19; Stuffy nose; Lost sense of smell & taste; This spontaneous case was reported by a health care professional and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Missed second vaccination dose.), NASAL CONGESTION (Stuffy nose), AGEUSIA (Lost sense of smell & taste) and COVID-19 (Tested positive for COVID-19) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jan-2021, the patient experienced NASAL CONGESTION (Stuffy nose) and AGEUSIA (Lost sense of smell & taste). On 08-Feb-2021, the patient experienced COVID-19 (Tested positive for COVID-19). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed second vaccination dose.). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Missed second vaccination dose.), NASAL CONGESTION (Stuffy nose), AGEUSIA (Lost sense of smell & taste) and COVID-19 (Tested positive for COVID-19) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   No concomitant medication reported  No treatment information was provided    This case was linked to MOD-2021-035838, MOD-2021-035856, MOD-2021-036378 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 04-Mar-2021: No specific follow-up information recorded.
Took the vaccine on Thursday felt bad on Friday with chills.  Saturday morning at 8:00  AM had fever and chills with a temperature at 100.8 one hour after receiving Ibuprofen.
Low grade fever, extreme fatigue, lightheaded, mild nausea, metal taste in mouth  for 7 days and counting (still running a low grade fever in the 99-101 range)
Expired vaccine was given as eight booster doses; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine was given as eight booster doses) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine was given as eight booster doses). On 02-Dec-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine was given as eight booster doses) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medicines were reported No treatment medicines were reported
2 mo rec'd DTP/OPV, following day developed temp of 99.2, encephalopathy, marked alteration in LOC, increased irritability & lethargy, duration of illness; 11 days, initial EEG abnormal; Repeat EEG showed improvement.
Coughing, flu like symptoms, stomach cramps, Headache, arm swelling and pain - AM 10/7/15.